

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to parathyroid hormone (GO:0071107) | 8.48469853 |
| 2 | one-carbon compound transport (GO:0019755) | 7.95545637 |
| 3 | metanephric nephron tubule development (GO:0072234) | 7.91134699 |
| 4 | metanephric tubule development (GO:0072170) | 7.91134699 |
| 5 | collecting duct development (GO:0072044) | 7.77808493 |
| 6 | actin filament depolymerization (GO:0030042) | 7.73508585 |
| 7 | metanephric nephron epithelium development (GO:0072243) | 7.20176747 |
| 8 | response to copper ion (GO:0046688) | 7.06384731 |
| 9 | lysine metabolic process (GO:0006553) | 6.85115781 |
| 10 | lysine catabolic process (GO:0006554) | 6.85115781 |
| 11 | metanephric epithelium development (GO:0072207) | 6.55285935 |
| 12 | cell volume homeostasis (GO:0006884) | 6.42248066 |
| 13 | positive regulation of catenin import into nucleus (GO:0035413) | 6.29678619 |
| 14 | urate metabolic process (GO:0046415) | 6.25905947 |
| 15 | response to lead ion (GO:0010288) | 6.21751541 |
| 16 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 5.91727599 |
| 17 | response to water (GO:0009415) | 5.91268337 |
| 18 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 5.82294708 |
| 19 | drug transmembrane transport (GO:0006855) | 5.78143758 |
| 20 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 5.62651299 |
| 21 | cellular copper ion homeostasis (GO:0006878) | 5.53482211 |
| 22 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 5.50183111 |
| 23 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.48080743 |
| 24 | nephron tubule development (GO:0072080) | 5.45102854 |
| 25 | negative regulation of cholesterol transport (GO:0032375) | 5.42510934 |
| 26 | negative regulation of sterol transport (GO:0032372) | 5.42510934 |
| 27 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.42098036 |
| 28 | response to thyroid hormone (GO:0097066) | 5.39992885 |
| 29 | negative regulation of metanephros development (GO:0072217) | 5.37141348 |
| 30 | water transport (GO:0006833) | 5.23612334 |
| 31 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.21094238 |
| 32 | NADH metabolic process (GO:0006734) | 5.09825500 |
| 33 | organic cation transport (GO:0015695) | 5.07142315 |
| 34 | drug transport (GO:0015893) | 5.00369047 |
| 35 | phosphate ion transport (GO:0006817) | 4.99936122 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 4.95463970 |
| 37 | tryptophan metabolic process (GO:0006568) | 4.88205369 |
| 38 | transepithelial transport (GO:0070633) | 4.83398409 |
| 39 | cardiovascular system development (GO:0072358) | 4.77570801 |
| 40 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.77102823 |
| 41 | 2-oxoglutarate metabolic process (GO:0006103) | 4.77002921 |
| 42 | renal tubule development (GO:0061326) | 4.73280973 |
| 43 | response to magnesium ion (GO:0032026) | 4.69776473 |
| 44 | fluid transport (GO:0042044) | 4.67151303 |
| 45 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.63938469 |
| 46 | cysteine metabolic process (GO:0006534) | 4.51715731 |
| 47 | pattern specification involved in kidney development (GO:0061004) | 4.51318387 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 4.50228188 |
| 49 | sodium-independent organic anion transport (GO:0043252) | 4.48164968 |
| 50 | glyoxylate metabolic process (GO:0046487) | 4.46124774 |
| 51 | branched-chain amino acid metabolic process (GO:0009081) | 4.45830340 |
| 52 | phosphate ion transmembrane transport (GO:0035435) | 4.41056579 |
| 53 | nephron epithelium development (GO:0072009) | 4.37532594 |
| 54 | response to growth hormone (GO:0060416) | 4.36860340 |
| 55 | response to vitamin A (GO:0033189) | 4.31511621 |
| 56 | quaternary ammonium group transport (GO:0015697) | 4.30420964 |
| 57 | regulation of protein localization to cell surface (GO:2000008) | 4.29465596 |
| 58 | branched-chain amino acid catabolic process (GO:0009083) | 4.28163538 |
| 59 | renal system process (GO:0003014) | 4.22525262 |
| 60 | hyperosmotic response (GO:0006972) | 4.22300612 |
| 61 | bone remodeling (GO:0046849) | 4.21263206 |
| 62 | sodium ion homeostasis (GO:0055078) | 4.20408897 |
| 63 | copper ion homeostasis (GO:0055070) | 4.13483432 |
| 64 | glycoside metabolic process (GO:0016137) | 4.08959232 |
| 65 | cellular response to ammonium ion (GO:0071242) | 4.08069811 |
| 66 | urogenital system development (GO:0001655) | 3.96577739 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 3.88251718 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 3.87281054 |
| 69 | ERK1 and ERK2 cascade (GO:0070371) | 3.85394982 |
| 70 | valine metabolic process (GO:0006573) | 3.85175902 |
| 71 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.82578851 |
| 72 | response to salt stress (GO:0009651) | 3.81948556 |
| 73 | tricarboxylic acid cycle (GO:0006099) | 3.80993332 |
| 74 | modified amino acid transport (GO:0072337) | 3.80632569 |
| 75 | protein depolymerization (GO:0051261) | 3.77420446 |
| 76 | mammary gland alveolus development (GO:0060749) | 3.74237743 |
| 77 | nephron tubule morphogenesis (GO:0072078) | 3.72593508 |
| 78 | nephron epithelium morphogenesis (GO:0072088) | 3.72593508 |
| 79 | homocysteine metabolic process (GO:0050667) | 3.68950544 |
| 80 | carnitine transport (GO:0015879) | 3.68414562 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.68414562 |
| 82 | cellular potassium ion homeostasis (GO:0030007) | 3.68189724 |
| 83 | regulation of somitogenesis (GO:0014807) | 3.67424649 |
| 84 | glomerular visceral epithelial cell development (GO:0072015) | 3.62506392 |
| 85 | inositol metabolic process (GO:0006020) | 3.62213810 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.59694544 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 3.59694544 |
| 88 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.59399890 |
| 89 | cellular ketone body metabolic process (GO:0046950) | 3.58492149 |
| 90 | tryptophan catabolic process (GO:0006569) | 3.57328738 |
| 91 | indole-containing compound catabolic process (GO:0042436) | 3.57328738 |
| 92 | indolalkylamine catabolic process (GO:0046218) | 3.57328738 |
| 93 | carnitine metabolic process (GO:0009437) | 3.57228861 |
| 94 | biotin metabolic process (GO:0006768) | 3.56353971 |
| 95 | kynurenine metabolic process (GO:0070189) | 3.54636933 |
| 96 | sodium ion transport (GO:0006814) | 3.53069705 |
| 97 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.52681982 |
| 98 | fatty acid beta-oxidation (GO:0006635) | 3.50663809 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.50057987 |
| 100 | L-phenylalanine catabolic process (GO:0006559) | 3.50057987 |
| 101 | indolalkylamine metabolic process (GO:0006586) | 3.49787099 |
| 102 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.46725671 |
| 103 | indole-containing compound metabolic process (GO:0042430) | 3.46210121 |
| 104 | copper ion transport (GO:0006825) | 3.44315005 |
| 105 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.44217619 |
| 106 | positive regulation of heat generation (GO:0031652) | 3.44028709 |
| 107 | cell differentiation involved in metanephros development (GO:0072202) | 3.43821987 |
| 108 | tyrosine metabolic process (GO:0006570) | 3.43132257 |
| 109 | serine family amino acid catabolic process (GO:0009071) | 3.42595578 |
| 110 | fructose metabolic process (GO:0006000) | 3.41900619 |
| 111 | aromatic amino acid family catabolic process (GO:0009074) | 3.40036953 |
| 112 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.39323574 |
| 113 | ATP synthesis coupled proton transport (GO:0015986) | 3.38260499 |
| 114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.38260499 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 3.37667922 |
| 116 | mesonephros development (GO:0001823) | 3.33580063 |
| 117 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.32650424 |
| 118 | fatty acid oxidation (GO:0019395) | 3.29872176 |
| 119 | glomerular epithelial cell development (GO:0072310) | 3.29723468 |
| 120 | trivalent inorganic anion homeostasis (GO:0072506) | 3.29657861 |
| 121 | phosphate ion homeostasis (GO:0055062) | 3.29657861 |
| 122 | bicarbonate transport (GO:0015701) | 3.27122736 |
| 123 | regulation of stem cell maintenance (GO:2000036) | 3.26308771 |
| 124 | lipid oxidation (GO:0034440) | 3.22776747 |
| 125 | regulation of fever generation (GO:0031620) | 3.21322517 |
| 126 | multicellular organismal water homeostasis (GO:0050891) | 3.19361957 |
| 127 | sodium ion export (GO:0071436) | 3.18219624 |
| 128 | cellular modified amino acid catabolic process (GO:0042219) | 3.17714250 |
| 129 | S-adenosylmethionine metabolic process (GO:0046500) | 3.17291618 |
| 130 | serine family amino acid metabolic process (GO:0009069) | 3.14646434 |
| 131 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.13972708 |
| 132 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.11524748 |
| 133 | vitamin transport (GO:0051180) | 3.11383569 |
| 134 | glutathione biosynthetic process (GO:0006750) | 3.08691331 |
| 135 | beta-amyloid metabolic process (GO:0050435) | 3.08585609 |
| 136 | positive regulation of digestive system process (GO:0060456) | 3.07215508 |
| 137 | regulation of catenin import into nucleus (GO:0035412) | 3.06562765 |
| 138 | hyperosmotic salinity response (GO:0042538) | 3.05962393 |
| 139 | negative regulation of kidney development (GO:0090185) | 3.05308041 |
| 140 | ketone body metabolic process (GO:1902224) | 3.04104129 |
| 141 | nephron tubule formation (GO:0072079) | 3.03817023 |
| 142 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.02310707 |
| 143 | regulation of cholesterol efflux (GO:0010874) | 3.00450920 |
| 144 | regulation of heat generation (GO:0031650) | 2.97855406 |
| 145 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.94111831 |
| 146 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.91937218 |
| 147 | kidney epithelium development (GO:0072073) | 2.90000277 |
| 148 | cellular hyperosmotic response (GO:0071474) | 2.89774807 |
| 149 | L-methionine salvage (GO:0071267) | 2.88678964 |
| 150 | L-methionine biosynthetic process (GO:0071265) | 2.88678964 |
| 151 | amino acid salvage (GO:0043102) | 2.88678964 |
| 152 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.87632868 |
| 153 | response to lithium ion (GO:0010226) | 2.84647173 |
| 154 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.84161198 |
| 155 | * inorganic anion transport (GO:0015698) | 2.74895227 |
| 156 | sulfur compound transport (GO:0072348) | 2.71729630 |
| 157 | polyol transport (GO:0015791) | 12.6226034 |
| 158 | * excretion (GO:0007588) | 11.0744145 |
| 159 | renal absorption (GO:0070293) | 10.7908011 |
| 160 | response to mercury ion (GO:0046689) | 10.6440709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.61530051 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.77789999 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.47944623 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22675400 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.96696701 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.59575021 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.35104337 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.18139275 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.99304127 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.70837434 |
| 11 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.48942268 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47160464 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.45733854 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.36520295 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32427986 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30690184 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.27982354 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27579836 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16867292 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.09509315 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.04387629 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01224979 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93348033 |
| 24 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.90142398 |
| 25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.89855682 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.89141712 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83028195 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81124497 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76022986 |
| 30 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.72640719 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69051619 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69026513 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66876565 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.66432495 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.63545140 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58655952 |
| 37 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.54827382 |
| 38 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54722629 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53378703 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53366307 |
| 41 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 1.52676108 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52376301 |
| 43 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.51956742 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.50796378 |
| 45 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.50796378 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49161091 |
| 47 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.49131569 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48881466 |
| 49 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47804152 |
| 50 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47254700 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.47042937 |
| 52 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.46493884 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.46137646 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.44083392 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41358468 |
| 56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41140044 |
| 57 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37523479 |
| 58 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.36100309 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35594335 |
| 60 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35241812 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34954124 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34389290 |
| 63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33701378 |
| 64 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31485533 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.30951562 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30210371 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28534785 |
| 68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.28356702 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27198199 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26817177 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26709996 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25564805 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25323740 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25025818 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24711921 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24523776 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23947619 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23690915 |
| 79 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.22916453 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22808755 |
| 81 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22741827 |
| 82 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22648057 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21651694 |
| 84 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21327083 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21314833 |
| 86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21185061 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20276769 |
| 88 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19506791 |
| 89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18694937 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16894324 |
| 91 | CBP_21632823_ChIP-Seq_H3396_Human | 1.16381552 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15020267 |
| 93 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14952550 |
| 94 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14423698 |
| 95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.13796850 |
| 96 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13714331 |
| 97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13052923 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12806922 |
| 99 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12229147 |
| 100 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.12120419 |
| 101 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11977630 |
| 102 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.11964738 |
| 103 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10888375 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09670832 |
| 105 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09238932 |
| 106 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.07980457 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07608577 |
| 108 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.07142850 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06614101 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05186037 |
| 111 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.04572668 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03650848 |
| 113 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03442866 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03286494 |
| 115 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02653693 |
| 116 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01249429 |
| 117 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01243428 |
| 118 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00444318 |
| 119 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.00310212 |
| 120 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00207408 |
| 121 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00012379 |
| 122 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99859598 |
| 123 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.99288426 |
| 124 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98761570 |
| 125 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98505877 |
| 126 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97827662 |
| 127 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97497533 |
| 128 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.97020495 |
| 129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96642514 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96194402 |
| 131 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.96170359 |
| 132 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95956595 |
| 133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95762719 |
| 134 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.95758921 |
| 135 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95629693 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95486942 |
| 137 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95209939 |
| 138 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95146862 |
| 139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95049035 |
| 140 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94608706 |
| 141 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.93558477 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93497770 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92626658 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91762690 |
| 145 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91464234 |
| 146 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.91259323 |
| 147 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90930740 |
| 148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90702202 |
| 149 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90135601 |
| 150 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90069059 |
| 151 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.89494986 |
| 152 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89136359 |
| 153 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88905472 |
| 154 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88276733 |
| 155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88224143 |
| 156 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88182974 |
| 157 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88137614 |
| 158 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.88109457 |
| 159 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87677973 |
| 160 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87677973 |
| 161 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87287210 |
| 162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.86433552 |
| 163 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85919155 |
| 164 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85873492 |
| 165 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.85805941 |
| 166 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85353865 |
| 167 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85208648 |
| 168 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.84234304 |
| 169 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.83083248 |
| 170 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82608487 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82607647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 9.79274086 |
| 2 | MP0003195_calcinosis | 8.01705852 |
| 3 | * MP0001756_abnormal_urination | 5.78677171 |
| 4 | MP0001765_abnormal_ion_homeostasis | 3.80977566 |
| 5 | MP0005360_urolithiasis | 3.78929865 |
| 6 | MP0005332_abnormal_amino_acid | 3.71353040 |
| 7 | * MP0009643_abnormal_urine_homeostasis | 3.70606029 |
| 8 | MP0004885_abnormal_endolymph | 3.48833334 |
| 9 | MP0005636_abnormal_mineral_homeostasis | 3.18673908 |
| 10 | * MP0002136_abnormal_kidney_physiology | 2.92573335 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.76655735 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.56394296 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.46748004 |
| 14 | MP0002168_other_aberrant_phenotype | 2.41537670 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.11825138 |
| 16 | MP0000538_abnormal_urinary_bladder | 2.00701868 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.74794943 |
| 18 | MP0005395_other_phenotype | 1.73529174 |
| 19 | MP0005670_abnormal_white_adipose | 1.66580502 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 1.60826376 |
| 21 | MP0003878_abnormal_ear_physiology | 1.60826376 |
| 22 | MP0008961_abnormal_basal_metabolism | 1.50557608 |
| 23 | MP0004742_abnormal_vestibular_system | 1.38296164 |
| 24 | MP0000534_abnormal_ureter_morphology | 1.37637957 |
| 25 | MP0003186_abnormal_redox_activity | 1.37314329 |
| 26 | MP0003252_abnormal_bile_duct | 1.36567074 |
| 27 | MP0001177_atelectasis | 1.35583947 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.30686617 |
| 29 | MP0005451_abnormal_body_composition | 1.30076156 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.25732492 |
| 31 | MP0003045_fibrosis | 1.24757834 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.24688633 |
| 33 | MP0003329_amyloid_beta_deposits | 1.23818624 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22542492 |
| 35 | MP0000230_abnormal_systemic_arterial | 1.20122521 |
| 36 | MP0002098_abnormal_vibrissa_morphology | 1.16384590 |
| 37 | MP0002234_abnormal_pharynx_morphology | 1.14866697 |
| 38 | MP0001270_distended_abdomen | 1.14778838 |
| 39 | MP0001958_emphysema | 1.13295651 |
| 40 | MP0005408_hypopigmentation | 1.11773679 |
| 41 | MP0000747_muscle_weakness | 1.09011324 |
| 42 | MP0002896_abnormal_bone_mineralization | 1.08605999 |
| 43 | MP0000371_diluted_coat_color | 1.06283726 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.05867787 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.05859627 |
| 46 | MP0005171_absent_coat_pigmentation | 1.02234859 |
| 47 | MP0002135_abnormal_kidney_morphology | 1.00337563 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 0.97974714 |
| 49 | MP0002163_abnormal_gland_morphology | 0.95331925 |
| 50 | MP0005365_abnormal_bile_salt | 0.93120921 |
| 51 | MP0002089_abnormal_postnatal_growth/wei | 0.89739809 |
| 52 | MP0003646_muscle_fatigue | 0.83721769 |
| 53 | MP0010386_abnormal_urinary_bladder | 0.83417938 |
| 54 | MP0005058_abnormal_lysosome_morphology | 0.81941116 |
| 55 | MP0002133_abnormal_respiratory_system | 0.81628540 |
| 56 | MP0005388_respiratory_system_phenotype | 0.81628540 |
| 57 | MP0009672_abnormal_birth_weight | 0.81255002 |
| 58 | MP0008872_abnormal_physiological_respon | 0.80860118 |
| 59 | MP0000372_irregular_coat_pigmentation | 0.80197701 |
| 60 | MP0001764_abnormal_homeostasis | 0.79700055 |
| 61 | MP0005535_abnormal_body_temperature | 0.76934352 |
| 62 | MP0003718_maternal_effect | 0.76225590 |
| 63 | MP0000681_abnormal_thyroid_gland | 0.75777854 |
| 64 | MP0005503_abnormal_tendon_morphology | 0.74025499 |
| 65 | MP0001485_abnormal_pinna_reflex | 0.73804488 |
| 66 | MP0008004_abnormal_stomach_pH | 0.72317000 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.71638216 |
| 68 | MP0003283_abnormal_digestive_organ | 0.70896857 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 0.66644250 |
| 70 | MP0003183_abnormal_peptide_metabolism | 0.65103562 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 0.64009582 |
| 72 | MP0002796_impaired_skin_barrier | 0.63172803 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.63098962 |
| 74 | MP0005275_abnormal_skin_tensile | 0.61278019 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.60437548 |
| 76 | MP0002928_abnormal_bile_duct | 0.59791937 |
| 77 | MP0001661_extended_life_span | 0.59611482 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.59224135 |
| 79 | MP0004215_abnormal_myocardial_fiber | 0.58987183 |
| 80 | MP0003315_abnormal_perineum_morphology | 0.58826763 |
| 81 | MP0004084_abnormal_cardiac_muscle | 0.57931495 |
| 82 | MP0009642_abnormal_blood_homeostasis | 0.55417214 |
| 83 | MP0003795_abnormal_bone_structure | 0.55221090 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 0.54625081 |
| 85 | MP0004272_abnormal_basement_membrane | 0.53167937 |
| 86 | MP0000604_amyloidosis | 0.52326906 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.51567151 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.51190478 |
| 89 | MP0003879_abnormal_hair_cell | 0.50572061 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.49975326 |
| 91 | MP0008260_abnormal_autophagy | 0.49331705 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.48476409 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.45620658 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.44997422 |
| 95 | MP0002971_abnormal_brown_adipose | 0.44575319 |
| 96 | MP0000609_abnormal_liver_physiology | 0.44187358 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.43679524 |
| 98 | MP0002132_abnormal_respiratory_system | 0.42515373 |
| 99 | MP0003938_abnormal_ear_development | 0.42374747 |
| 100 | MP0004233_abnormal_muscle_weight | 0.41904948 |
| 101 | MP0003953_abnormal_hormone_level | 0.41630005 |
| 102 | MP0009703_decreased_birth_body | 0.40766841 |
| 103 | MP0005501_abnormal_skin_physiology | 0.39847584 |
| 104 | MP0000026_abnormal_inner_ear | 0.39798471 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.39652393 |
| 106 | MP0003959_abnormal_lean_body | 0.39487742 |
| 107 | MP0001731_abnormal_postnatal_growth | 0.39431792 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.38646227 |
| 109 | MP0000462_abnormal_digestive_system | 0.38279406 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.37977482 |
| 111 | MP0002108_abnormal_muscle_morphology | 0.36986958 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.35529563 |
| 113 | MP0009697_abnormal_copulation | 0.34882047 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.33235310 |
| 115 | MP0001944_abnormal_pancreas_morphology | 0.33153946 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.33028948 |
| 117 | MP0009840_abnormal_foam_cell | 0.32936899 |
| 118 | MP0001666_abnormal_nutrient_absorption | 0.32934344 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.32698121 |
| 120 | MP0001191_abnormal_skin_condition | 0.32416741 |
| 121 | MP0002115_abnormal_skeleton_extremities | 0.31316799 |
| 122 | MP0005330_cardiomyopathy | 0.31086503 |
| 123 | MP0003632_abnormal_nervous_system | 0.29273591 |
| 124 | MP0000566_synostosis | 0.29119419 |
| 125 | MP0000367_abnormal_coat/_hair | 0.29107580 |
| 126 | MP0000750_abnormal_muscle_regeneration | 0.29101428 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.29085090 |
| 128 | MP0002295_abnormal_pulmonary_circulatio | 0.29030653 |
| 129 | MP0000163_abnormal_cartilage_morphology | 0.29016949 |
| 130 | MP0003941_abnormal_skin_development | 0.28950680 |
| 131 | MP0009780_abnormal_chondrocyte_physiolo | 0.28835163 |
| 132 | MP0000762_abnormal_tongue_morphology | 0.27966286 |
| 133 | MP0003011_delayed_dark_adaptation | 0.27303498 |
| 134 | MP0008775_abnormal_heart_ventricle | 0.26801972 |
| 135 | MP0002972_abnormal_cardiac_muscle | 0.23759941 |
| 136 | MP0004484_altered_response_of | 0.22508808 |
| 137 | MP0002082_postnatal_lethality | 0.22070172 |
| 138 | MP0010770_preweaning_lethality | 0.22070172 |
| 139 | MP0002127_abnormal_cardiovascular_syste | 0.20065331 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.20024593 |
| 141 | MP0002249_abnormal_larynx_morphology | 0.18984579 |
| 142 | MP0004085_abnormal_heartbeat | 0.18476877 |
| 143 | MP0010769_abnormal_survival | 0.18059000 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.16883054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of chloride homeostasis (HP:0011422) | 9.10379761 |
| 2 | Increased circulating renin level (HP:0000848) | 8.73746890 |
| 3 | * Renal salt wasting (HP:0000127) | 8.20271496 |
| 4 | * Hyperaldosteronism (HP:0000859) | 8.03678317 |
| 5 | Hypomagnesemia (HP:0002917) | 7.96326245 |
| 6 | * Polyuria (HP:0000103) | 7.66664819 |
| 7 | * Abnormal urine output (HP:0012590) | 7.04392640 |
| 8 | Abnormality of magnesium homeostasis (HP:0004921) | 6.77287010 |
| 9 | Abnormality of renin-angiotensin system (HP:0000847) | 6.71416114 |
| 10 | Abnormal drinking behavior (HP:0030082) | 6.42231048 |
| 11 | Polydipsia (HP:0001959) | 6.42231048 |
| 12 | * Alkalosis (HP:0001948) | 6.30105601 |
| 13 | Tetany (HP:0001281) | 6.25382631 |
| 14 | * Abnormality of renal excretion (HP:0011036) | 6.24441212 |
| 15 | * Hypokalemia (HP:0002900) | 5.02294439 |
| 16 | Gout (HP:0001997) | 4.73174115 |
| 17 | Decreased circulating renin level (HP:0003351) | 4.67891429 |
| 18 | * Abnormality of sodium homeostasis (HP:0010931) | 4.45313764 |
| 19 | * Abnormality of potassium homeostasis (HP:0011042) | 3.99298296 |
| 20 | Hypercalciuria (HP:0002150) | 3.90545845 |
| 21 | * Hyponatremia (HP:0002902) | 3.75296595 |
| 22 | * Adrenal overactivity (HP:0002717) | 3.70250600 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55966475 |
| 24 | Chondrocalcinosis (HP:0000934) | 3.39343082 |
| 25 | Dehydration (HP:0001944) | 3.33580659 |
| 26 | Hyperuricemia (HP:0002149) | 3.22942750 |
| 27 | Increased purine levels (HP:0004368) | 3.22942750 |
| 28 | Abnormality of Sharpey fibers (HP:0100685) | 3.22007247 |
| 29 | Hypotension (HP:0002615) | 3.13529101 |
| 30 | Hyperkalemia (HP:0002153) | 2.85343210 |
| 31 | Hyperglycinuria (HP:0003108) | 2.76730264 |
| 32 | Nephrocalcinosis (HP:0000121) | 2.72592407 |
| 33 | Chronic bronchitis (HP:0004469) | 2.71732760 |
| 34 | Renal tubular acidosis (HP:0001947) | 2.60890218 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 2.48080350 |
| 36 | Tubulointerstitial fibrosis (HP:0005576) | 2.41872080 |
| 37 | Proximal tubulopathy (HP:0000114) | 2.28690363 |
| 38 | Large eyes (HP:0001090) | 2.21750681 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.21639599 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21639599 |
| 41 | Glycosuria (HP:0003076) | 2.15400989 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 2.15400989 |
| 43 | Neonatal onset (HP:0003623) | 2.12718421 |
| 44 | Generalized muscle weakness (HP:0003324) | 2.08553048 |
| 45 | Vomiting (HP:0002013) | 2.06513349 |
| 46 | Hyperactive renin-angiotensin system (HP:0000841) | 11.3874580 |
| 47 | * Hypokalemic alkalosis (HP:0001949) | 11.3009017 |
| 48 | * Metabolic alkalosis (HP:0200114) | 10.1720503 |
| 49 | Renal tubular dysfunction (HP:0000124) | 1.96201232 |
| 50 | Ketoacidosis (HP:0001993) | 1.96042604 |
| 51 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92704995 |
| 52 | Rickets (HP:0002748) | 1.89192078 |
| 53 | Hyperphosphaturia (HP:0003109) | 1.88419653 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 1.82491260 |
| 55 | Ileus (HP:0002595) | 1.81551537 |
| 56 | Abnormality of cochlea (HP:0000375) | 1.81160129 |
| 57 | Vascular calcification (HP:0004934) | 1.80484472 |
| 58 | Metabolic acidosis (HP:0001942) | 1.76359104 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76059600 |
| 60 | Hypophosphatemia (HP:0002148) | 1.75463373 |
| 61 | Hyperglycinemia (HP:0002154) | 1.72885170 |
| 62 | Spinal muscular atrophy (HP:0007269) | 1.67651977 |
| 63 | Impaired platelet aggregation (HP:0003540) | 1.67618707 |
| 64 | Abnormal platelet function (HP:0011869) | 1.67618707 |
| 65 | Abnormal urine phosphate concentration (HP:0012599) | 1.65252959 |
| 66 | Generalized aminoaciduria (HP:0002909) | 1.62302381 |
| 67 | Nephrogenic diabetes insipidus (HP:0009806) | 1.59827738 |
| 68 | Ketosis (HP:0001946) | 1.59722741 |
| 69 | Cardiovascular calcification (HP:0011915) | 1.59443769 |
| 70 | Glomerulosclerosis (HP:0000096) | 1.56977612 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 1.55711323 |
| 72 | Tubular atrophy (HP:0000092) | 1.50804874 |
| 73 | Irritability (HP:0000737) | 1.49103247 |
| 74 | Nephrolithiasis (HP:0000787) | 1.47806426 |
| 75 | Facial shape deformation (HP:0011334) | 1.46136870 |
| 76 | Potter facies (HP:0002009) | 1.46136870 |
| 77 | Focal segmental glomerulosclerosis (HP:0000097) | 1.41669765 |
| 78 | Delayed CNS myelination (HP:0002188) | 1.39759788 |
| 79 | Tubulointerstitial abnormality (HP:0001969) | 1.37918506 |
| 80 | Hyperammonemia (HP:0001987) | 1.37024471 |
| 81 | Osteopenia (HP:0000938) | 1.36948977 |
| 82 | Thyroid-stimulating hormone excess (HP:0002925) | 1.35517591 |
| 83 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.34023697 |
| 84 | Abnormality of the renal medulla (HP:0100957) | 1.32974131 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 1.28720142 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.28720142 |
| 87 | Abnormality of the right ventricle (HP:0001707) | 1.28174778 |
| 88 | Abnormality of renal resorption (HP:0011038) | 1.26975982 |
| 89 | Neonatal death (HP:0003811) | 1.26681769 |
| 90 | Lethargy (HP:0001254) | 1.24634101 |
| 91 | Intellectual disability, moderate (HP:0002342) | 1.22754196 |
| 92 | Enlarged kidneys (HP:0000105) | 1.21142647 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 1.19859985 |
| 94 | Hydroxyprolinuria (HP:0003080) | 1.19859985 |
| 95 | Morphological abnormality of the inner ear (HP:0011390) | 1.19505225 |
| 96 | Paresthesia (HP:0003401) | 1.19306295 |
| 97 | Elevated alkaline phosphatase (HP:0003155) | 1.18103900 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 1.18054018 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.16767758 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.15828207 |
| 101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.11236593 |
| 102 | Male infertility (HP:0003251) | 1.07403434 |
| 103 | Abnormality of carpal bone ossification (HP:0006257) | 1.05821196 |
| 104 | Hypothermia (HP:0002045) | 1.05267784 |
| 105 | Osteomalacia (HP:0002749) | 1.04836126 |
| 106 | Delayed epiphyseal ossification (HP:0002663) | 1.04071552 |
| 107 | Metaphyseal cupping (HP:0003021) | 1.03356423 |
| 108 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.02762272 |
| 109 | Thin bony cortex (HP:0002753) | 1.01692958 |
| 110 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.01249419 |
| 111 | Esophageal varix (HP:0002040) | 1.00814038 |
| 112 | Bicornuate uterus (HP:0000813) | 1.00498807 |
| 113 | * Premature birth (HP:0001622) | 0.98217693 |
| 114 | Small for gestational age (HP:0001518) | 0.97266528 |
| 115 | Increased muscle lipid content (HP:0009058) | 0.97001887 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 0.96168020 |
| 117 | Spontaneous hematomas (HP:0007420) | 0.95315770 |
| 118 | Goiter (HP:0000853) | 0.94311106 |
| 119 | Lymphangioma (HP:0100764) | 0.93948130 |
| 120 | Hyperphosphatemia (HP:0002905) | 0.92514388 |
| 121 | Abnormal tarsal ossification (HP:0008369) | 0.88143784 |
| 122 | Hypophosphatemic rickets (HP:0004912) | 0.85281121 |
| 123 | Persistence of primary teeth (HP:0006335) | 0.83776017 |
| 124 | * Polyhydramnios (HP:0001561) | 0.83066285 |
| 125 | Abnormal hand bone ossification (HP:0010660) | 0.81270638 |
| 126 | Abnormality of macular pigmentation (HP:0008002) | 0.80205012 |
| 127 | Abnormality of the fingertips (HP:0001211) | 0.79805023 |
| 128 | Enlarged epiphyses (HP:0010580) | 0.78743785 |
| 129 | Abnormal ossification of hand bones (HP:0005921) | 0.76946088 |
| 130 | Confusion (HP:0001289) | 0.72856214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 7.32334651 |
| 2 | WNK4 | 5.53187656 |
| 3 | LMTK2 | 4.06673735 |
| 4 | SGK2 | 2.03364586 |
| 5 | STK39 | 2.01589384 |
| 6 | WNK3 | 12.1510960 |
| 7 | BCKDK | 1.91818906 |
| 8 | SGK223 | 1.90913691 |
| 9 | SGK494 | 1.90913691 |
| 10 | STK38L | 1.72838000 |
| 11 | SGK3 | 1.64888143 |
| 12 | PDK3 | 1.46239949 |
| 13 | PDK4 | 1.46239949 |
| 14 | PDK2 | 1.35556259 |
| 15 | MAP3K3 | 1.33662172 |
| 16 | WNK1 | 1.32781454 |
| 17 | NEK1 | 1.07828071 |
| 18 | PRKG2 | 0.82329701 |
| 19 | MST1R | 0.69841138 |
| 20 | TAOK1 | 0.68222235 |
| 21 | STK38 | 0.68113548 |
| 22 | MST4 | 0.67565429 |
| 23 | PRKAA1 | 0.64392422 |
| 24 | EPHA2 | 0.62161689 |
| 25 | BUB1 | 0.61632560 |
| 26 | PAK4 | 0.57459065 |
| 27 | TIE1 | 0.51349856 |
| 28 | PINK1 | 0.50570044 |
| 29 | MAP3K11 | 0.49847928 |
| 30 | MAPK15 | 0.49828463 |
| 31 | ERN1 | 0.49591330 |
| 32 | MAP2K3 | 0.47759204 |
| 33 | TTK | 0.46862465 |
| 34 | LRRK2 | 0.45731422 |
| 35 | RIPK1 | 0.42229541 |
| 36 | SGK1 | 0.41908847 |
| 37 | MAP3K7 | 0.39576826 |
| 38 | STK10 | 0.37230335 |
| 39 | WEE1 | 0.35202563 |
| 40 | MAP3K2 | 0.33328643 |
| 41 | AKT3 | 0.31745302 |
| 42 | TAOK2 | 0.28945392 |
| 43 | EIF2AK3 | 0.27047792 |
| 44 | PRKCI | 0.26056805 |
| 45 | INSRR | 0.25351351 |
| 46 | GRK6 | 0.25250487 |
| 47 | TESK1 | 0.23873670 |
| 48 | NLK | 0.23567389 |
| 49 | CSNK1A1 | 0.23488722 |
| 50 | CDC42BPA | 0.23278622 |
| 51 | ABL2 | 0.22304737 |
| 52 | DMPK | 0.21840665 |
| 53 | TSSK6 | 0.21801670 |
| 54 | GSK3A | 0.21504498 |
| 55 | DDR2 | 0.20516534 |
| 56 | FRK | 0.19928819 |
| 57 | ROCK1 | 0.19629699 |
| 58 | MARK3 | 0.18719887 |
| 59 | FER | 0.18563685 |
| 60 | SCYL2 | 0.18402395 |
| 61 | PRPF4B | 0.17776455 |
| 62 | TRIB3 | 0.17540100 |
| 63 | MET | 0.17283455 |
| 64 | SRPK1 | 0.16262179 |
| 65 | PIK3CG | 0.16062715 |
| 66 | PTK2 | 0.15287846 |
| 67 | PTK6 | 0.15239768 |
| 68 | NME1 | 0.15174747 |
| 69 | PRKCD | 0.15168698 |
| 70 | TGFBR2 | 0.14575496 |
| 71 | OBSCN | 0.14314952 |
| 72 | PNCK | 0.13868600 |
| 73 | MAP3K8 | 0.13787364 |
| 74 | KSR2 | 0.12807429 |
| 75 | ACVR1B | 0.12619514 |
| 76 | EIF2AK1 | 0.12313070 |
| 77 | PDPK1 | 0.12212492 |
| 78 | PRKACG | 0.10904376 |
| 79 | NTRK1 | 0.10438165 |
| 80 | BRSK2 | 0.10078120 |
| 81 | PRKACA | 0.09728923 |
| 82 | MAPKAPK3 | 0.07617160 |
| 83 | MTOR | 0.07277784 |
| 84 | PRKCZ | 0.07174309 |
| 85 | PRKD3 | 0.07015445 |
| 86 | FGFR2 | 0.06972739 |
| 87 | EPHB1 | 0.06489893 |
| 88 | PAK3 | 0.06337030 |
| 89 | AURKB | 0.05544304 |
| 90 | RPS6KA3 | 0.05480747 |
| 91 | PDK1 | 0.05140303 |
| 92 | NEK2 | 0.05115331 |
| 93 | IRAK2 | 0.05064938 |
| 94 | UHMK1 | 0.04845052 |
| 95 | NTRK3 | 0.04765804 |
| 96 | ZAK | 0.04668414 |
| 97 | LATS1 | 0.04514729 |
| 98 | RET | 0.04445206 |
| 99 | ROCK2 | 0.04357276 |
| 100 | LATS2 | 0.04337403 |
| 101 | PRKCA | 0.04007803 |
| 102 | SRC | 0.03812175 |
| 103 | BRD4 | 0.03676668 |
| 104 | FGFR4 | 0.03468396 |
| 105 | STK11 | 0.03371278 |
| 106 | STK24 | 0.03349001 |
| 107 | PRKCH | 0.03239340 |
| 108 | MELK | 0.03212538 |
| 109 | AURKA | 0.02809756 |
| 110 | NME2 | 0.02557004 |
| 111 | PRKCB | 0.02543771 |
| 112 | DAPK1 | 0.02020795 |
| 113 | MAPK10 | 0.01564753 |
| 114 | PRKCG | 0.01442142 |
| 115 | CSNK1G1 | 0.01415661 |
| 116 | AKT2 | 0.01293087 |
| 117 | FGFR3 | 0.00909133 |
| 118 | PIM1 | 0.00726616 |
| 119 | MYLK | 0.00241438 |
| 120 | MUSK | -0.0640405 |
| 121 | MAP2K1 | -0.0640149 |
| 122 | YES1 | -0.0574980 |
| 123 | ERBB2 | -0.0549329 |
| 124 | RPS6KA2 | -0.0454780 |
| 125 | MAPK1 | -0.0454656 |
| 126 | GSK3B | -0.0450288 |
| 127 | TRPM7 | -0.0404225 |
| 128 | MINK1 | -0.0399583 |
| 129 | MAPK8 | -0.0399364 |
| 130 | PRKAA2 | -0.0367504 |
| 131 | BMPR1B | -0.0361394 |
| 132 | PDGFRA | -0.0340619 |
| 133 | MAP2K2 | -0.0334499 |
| 134 | TAF1 | -0.0333549 |
| 135 | PRKG1 | -0.0325849 |
| 136 | PRKACB | -0.0322746 |
| 137 | MARK2 | -0.0320074 |
| 138 | PDGFRB | -0.0294906 |
| 139 | CSNK1G2 | -0.0238034 |
| 140 | TGFBR1 | -0.0235432 |
| 141 | CDK6 | -0.0164686 |
| 142 | PRKCE | -0.0144752 |
| 143 | STK3 | -0.0138168 |
| 144 | KSR1 | -0.0106070 |
| 145 | PRKD1 | -0.0104147 |
| 146 | PRKD2 | -0.0062552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.38205956 |
| 2 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.89862873 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.73898737 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.20870313 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.11670573 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.04622489 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.02135691 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.79375003 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.69643074 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56301649 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.41923140 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.41689336 |
| 13 | Mineral absorption_Homo sapiens_hsa04978 | 2.19737322 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.13139726 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.05823854 |
| 16 | Bile secretion_Homo sapiens_hsa04976 | 2.05005968 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.99369934 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.93678278 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.93023570 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86262355 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.85288702 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.83353261 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75947523 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71156594 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.67566809 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.66875813 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65422988 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.64295153 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62838989 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41656816 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39516193 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.32388076 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29981772 |
| 34 | Endometrial cancer_Homo sapiens_hsa05213 | 1.23952126 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19437208 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17943551 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09555894 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.09159213 |
| 39 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06151752 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03355642 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02320816 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01127906 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00452815 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97272776 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95136104 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93407734 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92094187 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91256251 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91126094 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90999990 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90555840 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86112778 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85326621 |
| 54 | Melanoma_Homo sapiens_hsa05218 | 0.84465649 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84074071 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.83732865 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83452345 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81778800 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81049883 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76325176 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75735712 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75560727 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75477244 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.71673194 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70650285 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.70500657 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70431298 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68990194 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.67917029 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64410513 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.64033127 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63506562 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62712281 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62690291 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60328058 |
| 76 | Prostate cancer_Homo sapiens_hsa05215 | 0.57949362 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.57111767 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55204576 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54167382 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54054533 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.53388165 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52109568 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51587364 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51260951 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50160765 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49956396 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49078201 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.48972017 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47914526 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45650763 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43975642 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43356603 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40603862 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37200232 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35753225 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35328977 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34853789 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33500439 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31139993 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29352521 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27424829 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.26122233 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25934934 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24531405 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23805479 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22680343 |
| 107 | Salivary secretion_Homo sapiens_hsa04970 | 0.21864112 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20870043 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20539441 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19818051 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19249323 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.17251598 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17122257 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.16442402 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16116429 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13650454 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.13078328 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10686344 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08557191 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07608194 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.05452679 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04624152 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.03106545 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.03026538 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02775430 |
| 126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.02505107 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0262467 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | -0.0239814 |

